Skip navigation

Search results for the

Showing 301 to 315 of 2023 results

Consultation on the draft Corporate Strategy

We are seeking views from all our stakeholders on this draft vision, and the other key components which make up our draft corporate strategy

Protected function - hearing aid dispensers

We regulate hearing aid dispensers on the basis of their professional title and also their protected function.

Prescribing

To be a prescriber means to have the legal authority to issue prescriptions

The standards of proficiency for arts therapists

The standards of proficiency that arts therapists must meet in order to join, and remain on, the HCPC Register. 

HCPC publishes Fitness to practise annual report 2019

The report highlights key statistics and insights and explains how we protect the public and ensure our registrants meet our standards

Embedding the revised standards of proficiency

We required that all education providers embedded our revised standards of proficiency (SOPs) from September 2023. We have assessed education provider alignment with the SOPs, and have considered common practices and challenges with this alignment.

Being LGBT+ in healthcare - LGBT+ History Month

To mark LGBT+ History Month 2024, two members of the UK SLT Pride Network tell us about their journeys in healthcare and how they have grappled with the barriers they face.

Launch date announced for specialist social work regulator

Nadhim Zahawi has announced Monday 2 December 2019 as the date when Social Work England will take over from the HCPC as the new social work regulator

The standards of proficiency for paramedics

The standards of proficiency that paramedics must meet in order to join, and remain on, the HCPC Register. 

Launch of consultation for the standards of conduct, performance and ethics

Today we have launched a consultation which outlines proposed changes to the Standards of conduct, performance and ethics.

Reclassification of Gabapentin and Pregabalin

From midnight on 1st April 2019, gabapentin and pregabalin will be reclassified as Schedule 3 controlled drugs, under the Misuse of Drugs Regulations (2001), and Class C of the Misuse of Drugs Act (1971)

Top